טוען...

Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice

CL 316,243, a β(3)-adrenergic agonist, was developed as an antiobesity and diabetes drug and causes rapid decreases in blood glucose levels in mice. The mechanisms mediating this effect have not been fully elucidated; thus, the purpose of the current study was to examine the role of fatty acids and...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: MacPherson, Rebecca E. K., Castellani, Laura, Beaudoin, Marie-Soleil, Wright, David C.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Physiological Society 2014
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187028/
https://ncbi.nlm.nih.gov/pubmed/25096179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00287.2014
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!